Technical Due Diligence, IP and Operational Support

3D Pharma Consulting provide support to companies to help prepare for investment, licensing and related commercial activities where potential partners will be conducting due diligence. We assess the strengths and weaknesses of the proposition and provide honest, in-depth insights and help build informed business plans, investment decks and data-rooms. We assist with due diligence meetings and visits (in-person and virtual), helping you to plan, prepare and deliver a high quality DD package.

We also help investors and companies to assess new opportunities, providing informed narrative on the technical aspects of the proposition, competitor analysis, data-room study and IP considerations.

What Our Clients Think

Working with Paul to develop long-acting injectable formulations has been an immensely helpful experience for us. Not only is he highly technically competent, but he is also incredibly easy to work with. His wealth of knowledge allows him to quickly understand any challenges we encounter and provide different methods to solve them in a timely manner. We greatly appreciate how he supports his suggestions with relevant documentation from the FDA, literature, or other credible sources, giving us...

Dr Karthik Raman

CEO | Persist AI, Woodland, CA, USA

Paul has brought a wealth of knowledge across pharmaceutical formulation development, analytical chemistry and manufacturing science. He has a positive, problem solving and professional manner that, combined with his industry knowledge, has provided Innoture with valuable support during internal and client facing drug development activities. His collaborative and friendly approach considers how Innoture is organised and our aims for the company, whilst also being keen to get his hands dirty w...

Ken Jones

CEO | Innoture Ltd

I would highly recommend Paul as a consultant; he has an in-depth knowledge of the pharmaceutical industry across a broad range of areas. Paul is proactive and works with clients to understand their objectives, he helped us to initiate a structured plan on how to enter the pharmaceutical sector and build a sustainable business model.

Ruth Mayes

Director Global Business Strategy | Computomics GmbH, Tübingen, Germany

Drawing on Paul’s track record of taking innovative processes from benchtop to GMP, we were delighted to work with him in preparing our technology for scale up. Paul understood our technology quickly, and provided us with a thorough analysis, relevant and practical advice and tangible output that was tailored to our needs as a small, but rapidly growing company

Dr Fran Crawford

CEO | SomaServe Ltd, Cambridge, UK

3D Pharma Consulting Ltd